{
  "name": "ISMP Targeted Best Practices and list guidance mapped to high-alert medication failure modes (2024-2025)",
  "description": "Compiled from ECRI/ISMP's 2024-2025 Targeted Medication Safety Best Practices announcement and ISMP's January 2024 high-alert list update; maps each practice or list-update item to the failure mode it addresses and the safeguard type. Wording quoted or paraphrased from the sources; no values estimated.",
  "page": "https://casrai.org/guides/high-alert-medications-list-safeguards",
  "publisher": "CASRAI",
  "license": "https://creativecommons.org/licenses/by/4.0/",
  "dateModified": "2026-11-13T20:49:04Z",
  "temporalCoverage": "2024/2025",
  "spatialCoverage": "United States",
  "columns": [
    {
      "name": "Item",
      "unit": "",
      "description": ""
    },
    {
      "name": "Failure mode addressed",
      "unit": "",
      "description": ""
    },
    {
      "name": "Safeguard type",
      "unit": "",
      "description": ""
    },
    {
      "name": "Source wording (quoted or paraphrased)",
      "unit": "",
      "description": ""
    },
    {
      "name": "Edition or date",
      "unit": "",
      "description": ""
    }
  ],
  "rows": [
    {
      "Item": "Best Practice 8: dose error-reduction smart pumps",
      "Failure mode addressed": "Programming or concentration-entry error on infusions",
      "Safeguard type": "Technology (forcing function / decision support)",
      "Source wording (quoted or paraphrased)": "Administer all medication and hydration infusions via a programmable infusion pump utilizing dose error-reduction systems; exception for rates beyond pump limits",
      "Edition or date": "2024-2025"
    },
    {
      "Item": "Best Practice 17: oxytocin infusions",
      "Failure mode addressed": "Concentration and bag-size variation",
      "Safeguard type": "Standardization",
      "Source wording (quoted or paraphrased)": "Standardize to a single concentration and bag size for antepartum and postpartum oxytocin infusions",
      "Edition or date": "2024-2025"
    },
    {
      "Item": "Best Practice 19: high-alert medications",
      "Failure mode addressed": "Single safeguard failing",
      "Safeguard type": "Layered strategies",
      "Source wording (quoted or paraphrased)": "Layers multiple strategies across the medication-use process for high-alert medications",
      "Edition or date": "2024-2025"
    },
    {
      "Item": "Best Practice 20: tranexamic acid",
      "Failure mode addressed": "Wrong-route/storage mix-up with look-alike anesthetic vials",
      "Safeguard type": "Storage separation, premixed product, labeling",
      "Source wording (quoted or paraphrased)": "Use premixed IV bags; do not store in an anesthesia tray if possible; keep separate from local anesthetics; consider vial-cap label",
      "Edition or date": "2024-2025 (new)"
    },
    {
      "Item": "High-alert list update: tranexamic acid injection added",
      "Failure mode addressed": "Neuraxial administration after storage/look-alike mix-up",
      "Safeguard type": "List inclusion",
      "Source wording (quoted or paraphrased)": "Added to ISMP List of High-Alert Medications in Acute Care Settings; neuraxial administration mortality about 50% per ISMP",
      "Edition or date": "January 2024"
    }
  ],
  "sources": [
    {
      "title": "Three New Best Practices in the 2024-2025 Targeted Medication Safety Best Practices for Hospitals (ECRI/ISMP)",
      "url": "https://home.ecri.org/blogs/ismp-alerts-and-articles-library/three-new-best-practices-in-the-2024-2025-targeted-medication-safety-best-practices-for-hospitals",
      "accessed": "2026-11-13"
    },
    {
      "title": "ISMP Updates High-Alert Medication List (ECRI/ISMP)",
      "url": "https://home.ecri.org/blogs/ismp-news/ismp-updates-high-alert-medication-list",
      "accessed": "2026-11-13"
    }
  ]
}